FEBRUARY 11, 2026 AT 11:01 AM

Niowave and Novartis (NOVN SW) enter global actinium-225 supply agreement to advance next-generation cancer therapies

Importance

Level 1

#SWITZERLAND #NOVARTIS AG #EQUITIES #EU SESSION #PHARMACEUTICALS #PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES #SWISS MARKET INDEX #NOVN #EUROPEAN EQUITIES

© 2026 Newsquawk. All rights reserved.